Stocks and InvestingStocks and Investing
Tue, March 2, 2021
Mon, March 1, 2021
Fri, February 26, 2021
Thu, February 25, 2021

Michael Wiederhorn Maintained (TDOC) at Buy with Increased Target to $270 on, Feb 25th, 2021


Published on 2024-10-27 15:46:27 - WOPRAI, Michael Wiederhorn
  Print publication without navigation


Michael Wiederhorn of Oppenheimer, Maintained "Teladoc Health, Inc." (TDOC) at Buy with Increased Target from $250 to $270 on, Feb 25th, 2021.

Michael has made no other calls on TDOC in the last 4 months.



There are 6 other peers that have a rating on TDOC. Out of the 6 peers that are also analyzing TDOC, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Scott Schoenhaus of "Stephens & Co." Downgraded from Buy to Hold on, Monday, December 7th, 2020
  • Robert Jones of "Goldman Sachs" Initiated at Hold and Held Target at $206 on, Friday, December 4th, 2020
  • Jamie Stockton of "Wells Fargo" Maintained at Hold with Increased Target to $200 on, Thursday, October 29th, 2020


These are the ratings of the 3 analyists that currently disagree with Michael


  • David Larsen of "BTIG" Initiated at Strong Buy and Held Target at $240 on, Thursday, January 7th, 2021
  • Matthew Gillmor of "Baird" Upgraded from Hold to Buy and Held Target at $220 on, Friday, November 13th, 2020
  • Richard Close of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $261 on, Thursday, October 29th, 2020